Portfolio Companies 2026 for Novartis: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Novartis accounts for 22 tracked companies with verified cap-table data, 22 of which disclose round sizes totalling $3B. The median disclosed raise is $115M, and the largest is Proteus Digital Health at $400M, ahead of Poseida Therapeutics ($313M) and Flare Therapeutics ($287M).
The names that recur most often on these portfolio cap tables are Novartis (22 companies), Invus (3 companies), GV (3 companies), Third Rock Ventures (2 companies), Nextech Invest (2 companies), Pfizer Ventures (2 companies). By latest disclosed round, the market skews Series C (6), Series B (4), Growth (3), Series A (3).
Companies tracked: 22
Disclosed funding total: $3B across 22 companies
Median disclosed raise: $115M
Largest raise: Proteus Digital Health — $400M
Stage mix: Series C 6 · Series B 4 · Growth 3 · Series A 3
